FogPharma raises $145 million in rare Series E round
FogPharma, an oncology startup based in Cambridge, Mass., recently closed a $145…
Antibiotic costs rise 1100% as big pharma exits Nigeria
Yemisi Bokinni, a freelance journalist in London, reports on the economic struggles…
Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma
Chimeric antigen receptor (CAR)-T cell therapy is a promising treatment for cancer,…
California hospitals, advocates seek stable funding to retain behavioral health navigators
Health providers and addiction experts are concerned about the unstable funding structure…
Exercise Tips for Overweight Kids
Motivating a child to exercise can be challenging if they aren't interested,…
Alzheimer’s Biomarker Changes 20 Years Before Diagnosis
A 20-year study tracked biomarker changes in adults progressing from normal cognition…
Insights From Experts During Eating Disorders Awareness Week
Eating disorders affect millions of people in the United States, with binge…
Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations
Biocon Biologics' facility at Biocon Campus (Site 1) received 4 observations from…
Startup Orbis Medicines Launches With €26M for Next-Generation Peptide Drugs
Orbis Medicines, a biotech company based in Copenhagen, aims to develop peptide-based…
“I Am Number 17” campaign opens at St Stephen’s Green, bringing visibility to Ireland’s rare disease community
The 'I Am Number 17' campaign in Ireland aims to bring awareness…